A detailed history of Broderick Brian C transactions in Pfizer Inc stock. As of the latest transaction made, Broderick Brian C holds 31,200 shares of PFE stock, worth $839,592. This represents 0.19% of its overall portfolio holdings.

Number of Shares
31,200
Previous 32,800 4.88%
Holding current value
$839,592
Previous $917,000 1.64%
% of portfolio
0.19%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$27.7 - $31.39 $44,320 - $50,224
-1,600 Reduced 4.88%
31,200 $902,000
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $44,205 - $51,800
-1,750 Reduced 5.07%
32,800 $917,000
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $709,282 - $814,483
27,396 Added 382.95%
34,550 $958,000
Q3 2020

Oct 28, 2020

BUY
$31.75 - $37.25 $227,139 - $266,486
7,154 New
7,154 $263,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $151,368 - $216,272
-5,600 Closed
0 $0
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $6,498 - $8,426
-200 Reduced 3.45%
5,600 $201,000
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $12,942 - $14,532
-350 Reduced 5.69%
5,800 $252,000
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $14,625 - $16,068
-390 Reduced 5.96%
6,150 $261,000
Q4 2018

Jan 24, 2019

SELL
$38.47 - $43.86 $30,776 - $35,088
-800 Reduced 10.9%
6,540 $285,000
Q3 2018

Oct 15, 2018

SELL
$34.47 - $41.81 $34,470 - $41,810
-1,000 Reduced 11.99%
7,340 $323,000
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $23,085 - $24,611
-700 Reduced 7.74%
8,340 $302,000
Q1 2018

Apr 24, 2018

SELL
$31.91 - $37.02 $22,337 - $25,914
-700 Reduced 7.19%
9,040 $321,000
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $320,726 - $340,301
-9,643 Reduced 49.75%
9,740 $353,000
Q3 2017

Oct 26, 2017

BUY
$31.0 - $34.15 $600,873 - $661,929
19,383
19,383 $691,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $151B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.